Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

ACCENDRA HEALTH INC.

Filed by NVG, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$80,000.00
Expenses
Not reported
Registrant
NVG, LLC
Filing UUID
a00e5630-65e8-4ed7-a8f2-a674321fc79d
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to electronic prescribing, including clinical data element template for Durable Medical Equipment. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Literal federal measure citations: H.R.2902, S.1406, S.4037

BUD · Budget/Appropriations

Report language for FY2027 Appropriations related to diabetes products and the Competitive Bidding Program.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.